EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Schisandrin A alleviates chondrocyte senescence and extracellular matrix degeneration by suppressing PI3K/Akt signaling pathway

Kecun Chen, Danqiu Xu, Yunrong Ding, Yanjun Cao, Huajun Bo

Bioscience, Biotechnology, and Biochemistry · 2026

DOI: 10.1093/bbb/zbag018 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Bioscience, Biotechnology, and Biochemistry, 2026. Verfasst von Kecun Chen und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Acupuncture and Massage, Shanghai Fourth People's Hospital, School of Medicine, Tongji University, 1279 San Men Road, Shanghai, China. Hauptthemen laut MEDLINE: Chondrocytes, Lignans, Cellular Senescence, Cyclooctanes. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 39 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Shanghai Municipal Health Commission.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Osteoarthritis (OA) is a progressive joint disorder characterized by inflammation and metabolic imbalance. Schisandrin A (Sch-A), a bioactive compound from Schisandra sphenanthera, is known for its anti-inflammatory and protective properties. This study investigated the effects of Sch-A on chondrocyte senescence and metabolism using IL-1β-stimulated CHON-001 cells as an in vitro OA model. Sch-A showed no cytotoxicity up to 100 μm and alleviated IL-1β-induced chondrocyte injury. It restored anabolic metabolism, suppressed catabolic activity, and reduced inflammatory and fibrotic responses. Bioinformatics indicated links between Sch-A, cellular senescence, and the PI3K/Akt pathway. Functional assays confirmed that Sch-A suppressed senescence-associated secretory phenotype factors, senescence markers, SA-β-galactosidase activity, and PI3K/Akt activation, while PI3K inhibition enhanced its anti-senescent effects. These findings suggest that Sch-A mitigates chondrocyte senescence and metabolic dysregulation by modulating PI3K/Akt signaling, supporting its therapeutic potential for OA.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

ChondrocytesLignansCellular SenescenceCyclooctanesProto-Oncogene Proteins c-aktPolycyclic CompoundsSignal TransductionPhosphatidylinositol 3-KinasesExtracellular MatrixAnimalsCell LineHumansInterleukin-1betaOsteoarthritis

Stichwörter der Autor:innen

PI3K/AktSchisandrin Acellular senescencemetabolismosteoarthritis

Substanzen

LignansCyclooctanesProto-Oncogene Proteins c-aktPolycyclic CompoundsPhosphatidylinositol 3-Kinasesschizandrin AInterleukin-1beta

Autor:innen und Institutionen

  • Department of Acupuncture and Massage, Shanghai Fourth People's Hospital, School of Medicine, Tongji University, 1279 San Men Road, Shanghai, China.

Förderung

  • Shanghai Municipal Health Commission

Zitieren

APA

Chen, K., Xu, D., Ding, Y., Cao, Y., & Bo, H. (2026). Schisandrin A alleviates chondrocyte senescence and extracellular matrix degeneration by suppressing PI3K/Akt signaling pathway. Bioscience, Biotechnology, and Biochemistry. https://doi.org/10.1093/bbb/zbag018

Vancouver

Chen K, Xu D, Ding Y, Cao Y, Bo H. Schisandrin A alleviates chondrocyte senescence and extracellular matrix degeneration by suppressing PI3K/Akt signaling pathway. Bioscience, Biotechnology, and Biochemistry. 2026. doi:10.1093/bbb/zbag018

BibTeX
@article{Chen2026,
  author = {Chen, Kecun and Xu, Danqiu and Ding, Yunrong and Cao, Yanjun and Bo, Huajun},
  title = {Schisandrin A alleviates chondrocyte senescence and extracellular matrix degeneration by suppressing PI3K/Akt signaling pathway},
  journal = {Bioscience, Biotechnology, and Biochemistry},
  year = {2026},
  doi = {10.1093/bbb/zbag018}
}
Kostenlos starten →